Green light from Health Canada for clinical phase entry of the UM171 compound

IRICoR congratulates Drs. Guy Sauvageau and Anne Marinier, along with their respective teams for obtaining Health Canada’s approval to start clinical trials with the UM171 compound.

For more information, please read the news on IRIC’s Website : Health Canada allows clinical trials for the molecule UM171

Guy_Sauvageau_Anne_Marinier_Sang_de_cordon_2014-09

© 2008-2020 IRICoR